XenoTherapeutics

XenoTherapeutics, founded in 2016, is a not-for-profit, clinical-stage regenerative medicine company with the slogan "Advancing Xenotransplantation to Therapeutic Reality." The company focuses on developing innovative cell and tissue-based research solutions. Their FDA-accepted pathogen screening and validated assays provide a robust regulatory pathway for the clinical advancement of xenogeneic cells, tissues, and organs. XenoTherapeutics aims to accelerate the development, testing, training, and commercialization of innovative, live biotherapeutic products, effectively delivering on the promise of regenerative medicine. As of now, there is no available information about the industries they operate in or their headquarters, and there have been no public records of their last investment or investors.